Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
about
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringImpact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patientsTrends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureAdherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort StudyCharacteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, ChinaControlling the HIV/AIDS epidemic: current status and global challengesSignificance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study.Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia.The emergence of drug resistant HIV variants and novel anti-retroviral therapy.Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection.Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.What do molecules do when we are not looking? State sequence analysis for stochastic chemical systems.Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
P2860
Q28482138-BC3CA494-C0F4-4D84-BEB4-7C0E86AAC775Q28483630-E8AC1D7F-39C4-4C08-8E8A-796BF103174AQ28488769-2E087EF0-592D-46C4-9CA4-E7EE9DE3DEF3Q28533767-9F69E08B-63E7-4C16-B83C-44997279FBE9Q28534423-5FE56B58-21EE-4B8E-9A5B-F0B7B31EAC69Q28539927-0984BD6C-E31B-4B61-BE17-2BB307E700DBQ30420558-39BC0C68-E973-4BDF-8F6B-7C6D3195CA99Q33798584-D3982C44-E0B9-4063-8CE4-38E781B285FAQ35577906-F6C3E422-9441-42CC-A0E7-CA3484B82BEAQ36113560-D2287359-7D5B-4061-8A59-7D079DFF25EBQ36184035-C7932BED-83B5-4F93-ACC1-161BFC998268Q36364052-5D118AB3-A8F4-4944-B097-4FE9FAAABDAEQ36963496-F6D87396-7622-4E01-9201-68A7CF4F3B08Q37036503-EE670BCC-DC52-4B52-8AE7-E10832914702Q38935015-7E924D84-26FC-40C6-B167-794D8BC79BFCQ41551955-74CCCD87-9185-4EA6-82FC-2165B2D4B939Q41848338-DA376DB0-52E2-47E9-892E-052FD5363ED0Q46926715-E992AEDD-9276-49D0-8550-915C7E7F9777
P2860
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@en
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@nl
type
label
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@en
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@nl
prefLabel
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@en
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@nl
P2093
P50
P356
P1476
Incidence of HIV-1 drug resist ...... g modern therapy combinations.
@en
P2093
Bruno Ledergerber
Cristina Cellerai
Cyril Shah
Pietro L Vernazza
P304
P356
10.1093/CID/CIR728
P407
P50
P577
2011-11-04T00:00:00Z